| 中文别名 |
吡唑蒽酮;炭疽[1,9-cd]吡唑-6(2H)-酮;1,9-吡唑并蒽酮;Anthra[1,9-cd]pyrazol-6(2H)-one 炭疽[1,9-cd]吡唑-6(2H)-酮;蒽并[1,9-cd]吡唑-6(2H)-酮;二苯并[cd,g]吲唑-6(2H)-酮;蒽并吡唑酮;蒽[1,9-CD]吡唑-6(2H)-酮;蒽并[1,9-cd]吡唑-6(2H)-酮;炭疽[1,9-CD]吡唑-6(2H)-酮;蒽并[1,9-CD]吡唑-6(2H)-酮 |
| 英文别名 |
Dibenzo[cd,g]indazol-6(2H)-one;Anthra[1,9-cd]pyrazol-6(2H)-one;SP600125;1 9-PYRAZOLEANTHRONE;1,9-Pyrazoloanthrone;2H-Dibenzo[CD,G]Indazol-6-One;SP600125 (NSC 75890,Pyrazolanthrone);SP-600125;JNKII;Nsc75890;c.i.70300;pyrazolanthrone;ANTHRAPYRAZOLONE;JNK INHIBITOR II;SP 600125;SP600125 >99%;InSolution™SP 600125, >=98%;FT-0607068;SW218106-2;Bio1_001313;Pyrazoleanthrone;BRN 0746890;BRD-K01567962-001-08-1;HMS3412F05;MLS002153267;2,6-dihydrodibenzo[cd,g]indazol-6-one;NSC 75890;ChemBiol10705 Compound 4;HMS3676F05;MLS002693964;KBio3_000772;SCHEMBL170980;UNII-1TW30Y2766;KBioGR_000406;Anthrapyrazolone; 1,9-Pyrazoloanthrone;2zmd;AKOS040751313;HMS3267P06;AKOS000115584;KBio2_002974;BiomolKI2_000072;F1414-1245;SR-01000075840;Bio1_000335;HMS3654P10;QTL1_000077;Bio2_000373;SY052909;BiomolKI_000068;AMY31086;NCGC00015958-06;SR-01000075840-4;BRD-K01567962-001-22-2;129-56-6;Lopac-S-5567;EN300-02083;CI 70300;BDBM16018;IDI1_002128;NSC-755773;Anthra[1,9-cd]pyrazol-6(2H)-one & Z-100;SMP2_000240;HB2234;anthra[1,9-cd]pyrazol-6-one;CS-0196;NCGC00015958-03;s10332;HY-12041;SP600125, >=98% (HPLC);Anthra-1,9-pyrazol-6-none;HMS2250C03;BDBM50433916;HMS3403F07;HMS1667K13;Kinome_3844;WLN: T C66651A P IV OMNJ;AB00075935-01;AS-14374;SCHEMBL15583517;KBio2_000406;NS00020981;GTPL5273;14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;KBio3_000771;ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE;HMS3261O08;SMR002530644;CBiol_002049;DTXCID0020525;CHEMBL1725279;KBioSS_000406;NCGC00025186-02;1TW30Y2766;1,6-dihydrodibenzo[cd,g]indazol-6-one;BRD-K01567962-001-06-5;EU-0100473;NCGC00015958-01;Tocris-1496;Bio1_000824;SR-01000075840-2;A888840;BCP05457;SP 600125 & Z-100;MLS006011577;NCGC00025186-05;HMS1362F07;NCGC00261158-01;EX-A1998;Z56785477;W-108360;SR-01000075840-1;NCGC00025186-01;NCGC00015958-07;Anthra[1,9-cd]pyrazol-6(2H)-one;SP-600125;K00068;JMC517015 Compound 2;SR-01000075840-6;SDCCGSBI-0050458.P003;Pyrazolanthrone (SP600125);NSC755773;HMS3229I16;NCGC00015958-02;14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;2h-dibenzo(cd,g)indazol-6-one;CHEBI:90695;LP00473;HMS3295M01;Anthra[1,9cd]pyrazol-6(2H)-one;KBio2_005542;CCG-47500;CHEMBL7064;BSPBio_001066;HMS3747M19;S 5567;C.I. 70300;Bio2_000853;HSCI1_000136;BCBcMAP01_000053;DB01782;CAS-129-56-6;NSC-75890;Dibenzo[cd,g]indazol-6(2H)-one #;Tox21_500473;Tox21_110267;EINECS 204-955-6;HMS1990F07;SMR000015440;JNK Inhibitor II - CAS 129-56-6;BRD-K01567962-001-04-0;WLN: T C6665 1A P IV OMNJ;Q4545713;1pmv;MFCD00022289;NCGC00015958-04;NCGC00015958-08;Lopac0_000473;NCGC00025186-04;SR-01000637108-1;NCGC00015958-05;BMK1-G8;Anthra[1-9-cd]pyrazol-6(2H)-one;NCGC00025186-03;s1460;DTXSID2040525;cid_8515;BDBM50024294;CCG-100672;AC-32051;14,15-diazatetracyclo[7.6.1.0;{2,7}.0;{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one;HMS1792F07;NCGC00015958-22;ALBB-024051;1PMV , JNK... |